Nuvectis Pharma (NVCT) Stock Chart & Stock Price History → Elon to Transform U.S. Economy? (From Porter & Company) (Ad) Free NVCT Stock Alerts $6.34 -0.19 (-2.91%) (As of 06/7/2024 08:52 PM ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Nuvectis Pharma Stock Price Performance5 Day Performance+4.11%1 Month Performance-0.94%3 Month Performance-38.21%6 Month Performance-22.59%Year-To-Date Performance-23.98%1 Year Performance-64.42% Receive NVCT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Nuvectis Pharma and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Market Moving TrendsTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Click to View The 5 Best AI Stocks to Invest In NVCT Stock Chart for Monday, June, 10, 2024 NVCT Chart by TradingView Nuvectis Pharma Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/07/2024$6.53$6.34-2.91%$6.75$6.1833,149 shs$116.40 million06/06/2024$6.09$6.53+7.22%$6.84$6.0669,825 shs$119.89 million06/05/2024$6.50$6.09-6.31%$6.70$5.95121,691 shs$111.79 million06/04/2024$6.54$6.50-0.61%$6.83$6.3540,968 shs$119.34 million06/03/2024$6.77$6.54-3.40%$6.90$6.4074,017 shs$120.07 million05/31/2024$6.40$6.77+5.78%$6.87$6.2076,420 shs$124.30 million Get the Latest News and Ratings for NVCT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Nuvectis Pharma and its competitors with MarketBeat's FREE daily newsletter. 05/30/2024$6.42$6.40-0.31%$6.67$6.2666,016 shs$117.50 million05/29/2024$6.58$6.42-2.43%$6.82$6.1650,036 shs$117.87 million05/28/2024$6.21$6.58+5.96%$7.00$6.3373,320 shs$120.81 million05/27/2024$6.21$6.21$6.85$6.1276,500 shs$114.02 million05/24/2024$6.68$6.21-7.04%$6.85$6.1276,589 shs$114.02 million05/23/2024$6.67$6.68+0.15%$7.37$6.55249,698 shs$122.65 million05/22/2024$6.08$6.67+9.70%$6.99$6.1068,824 shs$122.44 million05/21/2024$5.98$6.08+1.67%$6.16$5.87105,509 shs$111.63 million05/20/2024$6.15$5.98-2.76%$6.17$5.85199,810 shs$109.79 million05/17/2024$6.53$6.15-5.82%$6.60$6.07110,017 shs$112.91 million05/16/2024$6.65$6.53-1.80%$6.65$6.3525,436 shs$119.89 million05/15/2024$6.77$6.65-1.77%$6.80$6.05124,752 shs$122.09 million05/14/2024$6.35$6.77+6.61%$6.94$6.3672,896 shs$124.30 million05/13/2024$6.40$6.35-0.78%$6.69$6.3194,484 shs$116.59 million05/10/2024$6.38$6.40+0.31%$6.44$6.0085,864 shs$117.57 million05/09/2024$6.43$6.38-0.78%$6.59$6.2360,451 shs$117.21 million05/08/2024$7.19$6.43-10.57%$7.00$6.41182,961 shs$118.13 million05/07/2024$7.56$7.19-4.89%$7.81$6.79162,994 shs$132.09 million05/06/2024$8.14$7.56-7.13%$8.45$7.10185,062 shs$138.88 million05/03/2024$6.76$8.14+20.41%$8.29$6.91106,394 shs$149.53 million05/02/2024$6.65$6.76+1.65%$6.99$6.5330,633 shs$124.19 million05/01/2024$6.08$6.65+9.38%$7.17$6.15114,075 shs$118.17 million04/30/2024$6.38$6.08-4.70%$6.51$5.92266,455 shs$108.04 million04/29/2024$6.50$6.38-1.85%$6.73$6.3165,949 shs$113.37 million04/26/2024$6.51$6.50-0.15%$6.61$6.4321,307 shs$115.51 million04/25/2024$6.71$6.51-2.98%$6.79$6.3370,253 shs$115.68 million04/24/2024$6.59$6.71+1.82%$6.76$6.3350,696 shs$119.24 million04/23/2024$7.10$6.59-7.18%$7.39$6.5739,344 shs$117.10 million04/22/2024$6.82$7.10+4.11%$7.25$6.8124,872 shs$126.17 million04/19/2024$6.72$6.82+1.49%$6.85$6.4344,464 shs$121.19 million04/18/2024$6.76$6.72-0.59%$7.06$6.5680,804 shs$119.41 million04/17/2024$6.98$6.76-3.15%$7.33$6.5045,153 shs$120.13 million04/16/2024$6.41$6.98+8.89%$7.06$6.3866,215 shs$124.04 million04/15/2024$7.02$6.41-8.69%$7.24$6.30153,750 shs$113.91 millionElon Musk’s Final Masterpiece: “X-9840” (Ad)The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just released the details on what he’s calling Elon’s Project X-9840. Click here to see the details because there’s not much time to prepare.04/12/2024$7.42$7.02-5.39%$7.56$6.8534,937 shs$124.75 million04/11/2024$7.37$7.42+0.68%$7.49$7.0348,215 shs$131.85 million04/10/2024$7.69$7.37-4.16%$7.66$7.0963,893 shs$130.97 million04/09/2024$7.81$7.69-1.54%$7.95$7.5025,592 shs$136.64 million04/08/2024$7.78$7.81+0.39%$7.94$7.6224,325 shs$138.78 million04/05/2024$7.71$7.78+0.91%$7.89$7.6026,018 shs$138.25 million04/04/2024$8.25$7.71-6.55%$8.38$7.5837,109 shs$137.00 million04/03/2024$7.94$8.25+3.90%$8.40$7.7241,814 shs$146.60 million04/02/2024$7.93$7.94+0.13%$8.05$7.56110,337 shs$141.09 million04/01/2024$8.20$7.93-3.29%$8.49$7.80110,739 shs$140.92 million03/29/2024$8.20$8.20$8.74$8.1659,577 shs$145.71 million03/28/2024$8.34$8.20-1.68%$8.74$8.1659,577 shs$145.71 million03/27/2024$8.25$8.34+1.09%$8.50$8.0341,215 shs$148.20 million03/26/2024$8.89$8.25-7.20%$8.79$8.1645,352 shs$146.60 million03/25/2024$9.02$8.89-1.44%$9.45$8.6354,618 shs$157.98 million03/22/2024$9.05$9.02-0.33%$9.22$8.3534,360 shs$160.29 million03/21/2024$8.75$9.05+3.43%$9.25$8.3466,678 shs$160.82 million03/20/2024$8.77$8.75-0.23%$9.07$8.20131,006 shs$155.49 million03/19/2024$10.45$8.77-16.08%$11.00$8.51185,130 shs$155.83 million03/18/2024$11.00$10.45-5.00%$11.89$10.10340,323 shs$185.70 million03/15/2024$9.15$11.00+20.22%$11.30$9.10166,068 shs$195.47 million03/14/2024$9.64$9.15-5.08%$12.10$7.62435,825 shs$162.60 million03/13/2024$9.88$9.64-2.43%$10.02$9.0451,992 shs$171.30 million03/12/2024$10.15$9.88-2.66%$10.70$9.5769,512 shs$175.57 million03/11/2024$10.26$10.15-1.07%$10.50$9.67113,985 shs$180.37 million Related Companies: AVTE Stock Price Chart MREO Stock Price Chart KRRO Stock Price Chart ACIU Stock Price Chart ERAS Stock Price Chart VERV Stock Price Chart ALXO Stock Price Chart LXRX Stock Price Chart ESPR Stock Price Chart SLRN Stock Price Chart Receive NVCT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Nuvectis Pharma and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:NVCT) was last updated on 6/10/2024 by MarketBeat.com Staff From Our PartnersIt's time to ween off Chinese lithium!As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promi...Smallcaps Daily | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredRSVP: Charles Payne’s Cash Flow WorkshopDid you know you could "cash flow" the stocks in your portfolio? Without selling a single share of stock? ...Unstoppable Prosperity | SponsoredNvidia needs this one obscure firm In my new investigation, I detail why this is the single most important factor in the future of AI. I expla...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nuvectis Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nuvectis Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.